HARBIN, China, June 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One
 Medical, Inc. (AMEX:   CSY; "China Sky" or "the Company"), a manufacturer,
 marketer and distributor of pharmaceutical, medicinal and diagnostic kit
 products in China, announced today that Mr. Xiaoqing Liao has resigned as a
 Director, CFO and Board Secretary of China Sky One Medical, Inc. for
 personal reasons. The resignation was effective June 10, 2008.
 
     Mr. Liao joined the Company in March 2008, and had served in various
 capacities before being appointed to the role of CFO on May 7, 2008. Mr.
 Yukun Zhang, Financial Manager, will serve as interim CFO, and Ms. Yanwei
 Zhang, secretary to Mr. Yan-qing Liu, will serve as interim Board Secretary
 until a successor for Mr. Liao is named.
 
     "Mr. Liao has been a valuable member of our team and we appreciate his
 strong contribution and all he has accomplished, especially his efforts in
 ensuring the Company's successful migration to the American Stock
 Exchange," said Mr. Yan-qing Liu, Chairman, CEO and President of China Sky
 One Medical, Inc. "Given our strong growth, we plan to explore our options
 as we conduct a thorough search for a replacement for Mr. Liao who will
 meet our rigorous criteria."
 
     About China Sky One Medical, Inc.
 
     China Sky One Medical, Inc., a Nevada corporation, is engaged in the
 manufacturing, marketing and distribution of pharmaceutical, medicinal and
 diagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian
 Di Ren Medical Science and Technology Company ("TDR") and Harbin First Bio-
 Engineering Company Limited ("First"), the Company manufactures and
 distributes over-the-counter pharmaceutical products as its primary revenue
 source. For more information, visit http://www.skyonemedical.com .
 
     Safe Harbor Statement
 
     Certain statements made in this press release constitute
 forward-looking statements within the meaning of the Private Securities
 Litigation Reform Act of 1995. These statements can be identified by the
 use of forward-looking terminology such as "believe," "expect," "may,"
 "will," "should," "project," "plan," "seek," "intend," or "anticipate" or
 the negative thereof or comparable terminology. Such statements typically
 involve risks and uncertainties and may include financial projections or
 information regarding our future plans, objectives or performance. The
 Company cannot provide any assurance that its application to list on the
 American Stock Exchange will be approved or that the liquidity and
 marketability of its shares will improve. Actual results could differ
 materially from the expectations reflected in such forward-looking
 statements as a result of a variety of factors, including the inability of
 the company to meet the listing standards, risks associated with the effect
 of changing economic conditions in The People's Republic of China,
 variations in cash flow, reliance on collaborative retail partners and on
 new product development, variations in new product development, risks
 associated with rapid technological change, and the potential of introduced
 or undetected flaws and defects in products, and other risk factors
 detailed in reports filed with the Securities and Exchange Commission from
 time to time.
 
 

     For more information, please contact:
 
     China Sky One Medical, Inc.
      Mr. Yan-qing Liu
      Chairman, CEO & President
      Phone: +86-451-5399-4069
      Email: cntiandiren@yahoo.com.cn
 
     CCG Elite Investor Relations Inc.
      Mr. Crocker Coulson, President
      Phone: +1-646-213-1915 (New York)
      Email: crocker.coulson@ccgir.com
      Website: http://www.ccgelite.com
 
 

SOURCE China Sky One Medical, Inc.

Back to top